Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


How the RPS helped make FMD 'fit for purpose in the UK'


Thank you for your feedback on this article, Dilip and Rajesh. We appreciate your input, and would like to assure you that The Pharmaceutical Journal recognises the work done by the NPA and the UK FMD Working Group in ensuring that FMD legislation will be workable in the UK. We have covered some of these achievements in previous articles: Falsified Medicines Directive: opportunity or obstacle? Hub on EU falsified medicines directive developed for UK pharmacists The article to which you refer was published in the Your RPS section of the journal, which focuses on activities of the RPS. As such, it concentrates on a recent presentation about FMD given by Aileen Bryson to a conference for hospital pharmacists. In 2018 the journal will be continuing to cover matters related to FMD as the deadline for full implementation into UK law approaches, and we will be seeking input from the NPA, the UK FMD Working Group, and all other invested bodies as we put this material together. In the meantime if you have any further feedback, or suggestions for FMD news that we ought to be covering now, please do contact us.

Posted date

13 DEC 2017

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.